These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 35632981)

  • 1. Circulating tumor cells in neuroblastoma: Current status and future perspectives.
    Yang R; Zheng S; Dong R
    Cancer Med; 2023 Jan; 12(1):7-19. PubMed ID: 35632981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of liquid biopsy in the management of cancer patients.
    Markou A; Tzanikou E; Lianidou E
    Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
    Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
    Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell next-generation sequencing of circulating tumor cells in patients with neuroblastoma.
    Kojima M; Harada T; Fukazawa T; Kurihara S; Touge R; Saeki I; Takahashi S; Hiyama E
    Cancer Sci; 2023 Apr; 114(4):1616-1624. PubMed ID: 36571449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review.
    Aktar S; Baghaie H; Islam F; Gopalan V; Lam AK
    Otolaryngol Head Neck Surg; 2023 May; 168(5):988-1005. PubMed ID: 36939466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization.
    Liu X; Zhang Z; Zhang B; Zheng Y; Zheng C; Liu B; Zheng S; Dong K; Dong R
    EBioMedicine; 2018 Sep; 35():244-250. PubMed ID: 30104180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
    Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS
    Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib.
    Punnoose EA; Atwal S; Liu W; Raja R; Fine BM; Hughes BG; Hicks RJ; Hampton GM; Amler LC; Pirzkall A; Lackner MR
    Clin Cancer Res; 2012 Apr; 18(8):2391-401. PubMed ID: 22492982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic Biomarkers.
    Merugu S; Chen L; Gavens E; Gabra H; Brougham M; Makin G; Ng A; Murphy D; Gabriel AS; Robinson ML; Wright JH; Burchill SA; Humphreys A; Bown N; Jamieson D; Tweddle DA
    Clin Cancer Res; 2020 Jan; 26(1):122-134. PubMed ID: 31767563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
    Fici P
    Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
    Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
    Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
    Radovich M; Jiang G; Hancock BA; Chitambar C; Nanda R; Falkson C; Lynce FC; Gallagher C; Isaacs C; Blaya M; Paplomata E; Walling R; Daily K; Mahtani R; Thompson MA; Graham R; Cooper ME; Pavlick DC; Albacker LA; Gregg J; Solzak JP; Chen YH; Bales CL; Cantor E; Shen F; Storniolo AMV; Badve S; Ballinger TJ; Chang CL; Zhong Y; Savran C; Miller KD; Schneider BP
    JAMA Oncol; 2020 Sep; 6(9):1410-1415. PubMed ID: 32644110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy in CNS tumors: Current status & future perspectives.
    Husain N; Husain A; Mishra S; Srivastava P
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer.
    Gerratana L; Davis AA; Zhang Q; Basile D; Rossi G; Strickland K; Franzoni A; Allegri L; Mu Z; Zhang Y; Flaum LE; Damante G; Gradishar WJ; Platanias LC; Behdad A; Yang H; Puglisi F; Cristofanilli M
    JCO Precis Oncol; 2021 Jun; 5():943-952. PubMed ID: 34136741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Minimal Residual Disease in Neuroblastoma Patients.
    Uemura S; Ishida T; Thwin KKM; Yamamoto N; Tamura A; Kishimoto K; Hasegawa D; Kosaka Y; Nino N; Lin KS; Takafuji S; Mori T; Iijima K; Nishimura N
    Front Oncol; 2019; 9():455. PubMed ID: 31214500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers.
    Zhang Z; Wu H; Chong W; Shang L; Jing C; Li L
    Cell Death Dis; 2022 Oct; 13(10):903. PubMed ID: 36302755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor DNA in neuroblastoma.
    Wei M; Ye M; Dong K; Dong R
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28311. PubMed ID: 32729220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
    Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Mastoraki S; Strati A; Tzanikou E; Chimonidou M; Politaki E; Voutsina A; Psyrri A; Georgoulias V; Lianidou E
    Clin Cancer Res; 2018 Mar; 24(6):1500-1510. PubMed ID: 29284708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.